EMEA-000311-PIP04-13-M04

Table of contents

Key facts

Invented name
Stelara
Active substance
Ustekinumab
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0401/2022
PIP number
EMEA-000311-PIP04-13-M04
Pharmaceutical form(s)
  • Solution for injection/infusion
  • Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of Crohn's disease
Route(s) of administration
  • Subcutaneous use
  • Intravenous use
Contact for public enquiries
Janssen Cilag International NV

Tel. +3214602111
E-mail: contact@Janssen-emea.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating